Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.

However, not all companies with momentum are long-term winners, and many investors have lost money by following short-term trends. Keeping that in mind, here are three stocks that are likely overheated and some you should look into instead.

Texas Instruments (TXN)

One-Month Return: +39.4%

Headquartered in Dallas, Texas since the 1950s, Texas Instruments (NASDAQ: TXN) is the world’s largest producer of analog semiconductors.

Why Does TXN Give Us Pause?

1. Scale is a double-edged sword because it limits the company’s growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 3.6% for the last five years
2. Demand will likely be soft over the next 12 months as Wall Street’s estimates imply tepid growth of 9.3%
3. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 10.8 percentage points

At $263.04 per share, Texas Instruments trades at 34.4x forward P/E. To fully understand why you should be careful with TXN, check out our full research report (it’s free).

Arrow Electronics (ARW)

One-Month Return: +29.7%

Founded as a single retail store, Arrow Electronics (NYSE: ARW) provides electronic components and enterprise computing solutions to businesses globally.

Why Do We Avoid ARW?

1. Sales tumbled by 3.5% annually over the last two years, showing market trends are working against its favor during this cycle
2. Sales were less profitable over the last two years as its earnings per share fell by 19.7% annually, worse than its revenue declines
3. Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability

Arrow Electronics’s stock price of $181.43 implies a valuation ratio of 12.9x forward P/E. Read our free research report to see why you should think twice about including ARW in your portfolio.

agilon health (AGL)

One-Month Return: +157%

Transforming how doctors care for seniors by shifting financial incentives from volume to outcomes, agilon health (NYSE: AGL) provides a platform that helps primary care physicians transition to value-based care models for Medicare patients through long-term partnerships and global capitation arrangements.

Why Are We Cautious About AGL?

1. Sales are projected to tank by 8% over the next 12 months as demand evaporates
2. Efficiency has decreased over the last five years as its adjusted operating margin fell by 3.6 percentage points
3. Cash-burning tendencies make us wonder if it can sustainably generate shareholder value

agilon health is trading at $28.27 per share, or 0.1x forward price-to-sales. Dive into our free research report to see why there are better opportunities than AGL.

Stocks We Like More

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.